This paper is in the following e-collection/theme issue:

E-Health / Health Services Research and New Models of Care (517) Gastroenterology and Hepatology (68) Health Services Research (482) Health Care Quality and Health Services Research (271)

Published on in Vol 23, No 1 (2021): January

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/20629, first published .
Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study

Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study

Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study

Authors of this article:

Qiao Yu1 Author Orcid Image ;   Chunpeng Zhu1 Author Orcid Image ;   Shuyi Feng1 Author Orcid Image ;   Liyi Xu1 Author Orcid Image ;   Shurong Hu1 Author Orcid Image ;   Hao Chen1 Author Orcid Image ;   Hanwen Chen1 Author Orcid Image ;   Sheng Yao1 Author Orcid Image ;   Xiaoying Wang1 Author Orcid Image ;   Yan Chen1 Author Orcid Image
Article Authors Cited by (30) Tweetations (3) Metrics

Journals

  1. Zhou T, Sheng Y, Guan H. Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China. Advances in Therapy 2021;38(8):4233 View
  2. Wu L, Lv Z, Lai L, Zhou P. Assessment of influencing factors of hospitalization expenses for Crohn's disease patients: Based on LASSO and linear mixed model. Frontiers in Public Health 2022;10 View
  3. Güney Coşkun M, Kolay E, Basaranoglu M. Telenutrition for the management of inflammatory bowel disease: Benefits, limits, and future perspectives. World Journal of Clinical Cases 2023;11(2):308 View
  4. Wang Y, Li S, Gong J, Cao L, Xu D, Yu Q, Wang X, Chen Y. Perceived Stigma and Self-Efficacy of Patients With Inflammatory Bowel Disease-Related Stoma in China: A Cross-Sectional Study. Frontiers in Medicine 2022;9 View
  5. Ali H, Patel P, Dhillon R, Sarfraz S, Poola S, Smith-Martinez L, Fatakhova K, Rajapakse R. Disparities and trends in suicidal ideations for inflammatory bowel disease hospitalizations: a decade-long national database analysis. Exploration of Medicine 2023:23 View
  6. Li S, Li P, Sun H, Hu W, Hu S, Chen Y, Lv M. Medication Belief is Associated with Improved Adherence to Exclusive Enteral Nutrition in Patients with Crohn’s Disease. Patient Preference and Adherence 2021;Volume 15:2327 View
  7. Yang D, Li Y, Sun H, He C, Chen G, Zhao Z, Tang T, M'Koma A. A Study on Differences between Professional Endoscopists and Gastroenterologists in Endoscopic Detection and Standard Pathological Biopsy of Inflammatory Bowel Diseases. Gastroenterology Research and Practice 2022;2022:1 View
  8. Zhang Y, Liu J, Han X, Jiang H, Zhang L, Hu J, Shi L, Li J. Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019. Frontiers in Public Health 2022;10 View
  9. Zhou T, Sheng Y, Guan H, Meng R, Wang Z. Cost-Effectiveness Analysis of Vedolizumab Compared With Infliximab in Anti-TNF-α-Naïve Patients With Moderate-to-Severe Ulcerative Colitis in China. Frontiers in Public Health 2021;9 View
  10. Peng Z, Xu D, Li Y, Peng Y, Liu X. Phase Angle as a Comprehensive Tool for Nutritional Monitoring and Management in Patients with Crohn’s Disease. Nutrients 2022;14(11):2260 View
  11. Fazal F, Ur Rehman M, asif O, Mustafa H, tanveer U, haider T, Khalid A, saeed S, basit J. Telemedicine: A promising future for inflammatory bowel disease management. Annals of Medicine and Surgery 2022;82:104684 View
  12. Peng L, Hu S, Yu Q, Chen Y. Challenging the Surge of Inflammatory Bowel Disease: The Role of the China Crohn’s and Colitis Foundation in the Healthcare Landscape of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2022;28(Supplement_2):S9 View
  13. Shao B, Yang W, Cao Q. Landscape and predictions of inflammatory bowel disease in China: China will enter the Compounding Prevalence stage around 2030. Frontiers in Public Health 2022;10 View
  14. Chen C, Cao J, Wang Y, Han X, Zhang Y, Zhuang S. Health-Related Quality of Life and Thyroid Cancer-Specific Symptoms in Patients Treated for Differentiated Thyroid Cancer: A Single-Center Cross-Sectional Survey from Mainland China. Thyroid 2023;33(4):474 View
  15. Ma T, Wan M, Liu G, Zuo X, Yang X, Yang X. Temporal Trends of Inflammatory Bowel Disease Burden in China from 1990 to 2030 with Comparisons to Japan, South Korea, the European Union, the United States of America, and the World. Clinical Epidemiology 2023;Volume 15:583 View
  16. Wang Y, Zhang C, Zhou Y. Reconstructing self from the illness: a constructivist grounded theory study of posttraumatic growth in patients with Crohn’s disease. BMC Gastroenterology 2023;23(1) View
  17. Dengler F, Domenig O, Kather S, Burgener I, Steiner J, Heilmann R. Dysregulation of intestinal epithelial electrolyte transport in canine chronic inflammatory enteropathy and the role of the renin-angiotensin-aldosterone-system. Frontiers in Veterinary Science 2023;10 View
  18. Heilmann R, Csukovich G, Burgener I, Dengler F. Time to eRAASe chronic inflammation: current advances and future perspectives on renin-angiotensin-aldosterone-system and chronic intestinal inflammation in dogs and humans. Frontiers in Veterinary Science 2023;10 View
  19. van Kessel R, Roman-Urrestarazu A, Anderson M, Kyriopoulos I, Field S, Monti G, Reed S, Pavlova M, Wharton G, Mossialos E. Mapping Factors That Affect the Uptake of Digital Therapeutics Within Health Systems: Scoping Review. Journal of Medical Internet Research 2023;25:e48000 View
  20. Feng J, Chen Y, Liu Y, Lin L, Lin X, Gong W, Xia R, He J, Sheng J, Cai H, Xiao C. Efficacy and safety of fecal microbiota transplantation in the treatment of ulcerative colitis: a systematic review and meta-analysis. Scientific Reports 2023;13(1) View
  21. Meng Y, Chung D, Zhang A, Al Mamun A. The effect of social media environmental information exposure on the intention to participate in pro-environmental behavior. PLOS ONE 2023;18(11):e0294577 View
  22. Zhang F, Cui Y, Gao X. Time trends in the burden of autoimmune diseases across the BRICS: an age–period–cohort analysis for the GBD 2019. RMD Open 2023;9(4):e003650 View
  23. Gong S, Zhang Y, Wang Y, Yang X, Cheng B, Song Z, Liu X. Study on the burden of digestive diseases among Chinese residents in the 21st century. Frontiers in Public Health 2024;11 View
  24. Chen L, Zhou Y. Symptom management experiences of Chinese individuals with Crohn's disease: A longitudinal descriptive qualitative study. Research in Nursing & Health 2024;47(4):423 View
  25. Youssef M, Hossein-Javaheri N, Hoxha T, Mallouk C, Tandon P. Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2024;18(9):1486 View
  26. Li J, Xie G, Tang W, Zhang L, Zhang Y, Zhang L, Wang D, Li K. Establishing a machine learning model based on dual-energy CT enterography to evaluate Crohn’s disease activity. Insights into Imaging 2024;15(1) View
  27. Wagner F, Schreiber S, Bagger Y, Bruzelius K, Falahati A, Sternebring O, Ravi A, Pinton P. Safety, tolerability, and pharmacokinetics of single‐ and multiple‐ascending doses of olamkicept: Results from randomized, placebo‐controlled, first‐in‐human phase I trials. Clinical and Translational Science 2024;17(5) View
  28. Zeng Z, Lin H, Jiang M, Yuan J, Li X, Jia Y, Yang L, Zhang H. Anti-TNFα in inflammatory bowel disease: from originators to biosimilars. Frontiers in Pharmacology 2024;15 View
  29. Wu D, Lin Q, Wang Z, Huang H, Song X, Gao Y, Yang X, Wen K, Sun X. Mechanism of Xue-Jie-San treating Crohn's disease complicated by atherosclerosis: Network pharmacology, molecular docking and experimental validation. Phytomedicine 2024;135:156169 View
  30. Zhou Y, Qiao R, Ding T, Li H, Zhang P. An uncertain future: perspectives of emerging adults with inflammatory bowel disease—a qualitative semistructured interview study in eastern China. BMJ Open 2024;14(11):e089213 View